Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles G Drake

Showing results (111-120 of 266) with videos related to

Pageof 27
Sort By:
The Prostate|July 13, 2011
Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancerDaniel J Zabransky, Heath A Smith, Christopher J Thoburn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2014
A peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE IINrupen A Bhavsar, Jay H Bream, Alan K Meeker, et al.
Disease Models & Mechanisms|September 30, 2018
Cooperation of loss of <i>NKX3.1</i> and inflammation in prostate cancer initiationClémentine Le Magnen, Renu K Virk, Aditya Dutta, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2016
Circulating Beta-2 Microglobulin and Risk of Cancer: The Atherosclerosis Risk in Communities Study (ARIC)Anna E Prizment, Amy M Linabery, Pamela L Lutsey, et al.
Cancer Causes & Control : CCC|February 6, 2010
Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studiesElizabeth A Platz, Siobhan Sutcliffe, Angelo M De Marzo, et al.
International Journal of Cancer|February 5, 2015
Asthma and risk of lethal prostate cancer in the Health Professionals Follow-Up StudyElizabeth A Platz, Charles G Drake, Kathryn M Wilson, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy responseCasey R Ager, Mingxuan Zhang, Matthew Chaimowitz, et al.
Journal of the National Cancer Institute|March 8, 2020
Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-TRavi A Madan, Emmanuel S Antonarakis, Charles G Drake, et al.
Cancer Investigation|June 24, 2010
Immune signatures predict prognosis in localized cancerDavid S Hsu, Mickey K Kim, Bala S Balakumaran, et al.
Cancer Immunology Research|June 7, 2015
A Paracrine Role for IL6 in Prostate Cancer Patients: Lack of Production by Primary or Metastatic Tumor CellsShu-Han Yu, Qizhi Zheng, David Esopi, et al.
Pageof 27

Showing results (111-120 of 266) with videos related to

Sort By:
Pageof 27
The Prostate|July 13, 2011
Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancerDaniel J Zabransky, Heath A Smith, Christopher J Thoburn, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2014
A peripheral circulating TH1 cytokine profile is inversely associated with prostate cancer risk in CLUE IINrupen A Bhavsar, Jay H Bream, Alan K Meeker, et al.
Disease Models & Mechanisms|September 30, 2018
Cooperation of loss of <i>NKX3.1</i> and inflammation in prostate cancer initiationClémentine Le Magnen, Renu K Virk, Aditya Dutta, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2016
Circulating Beta-2 Microglobulin and Risk of Cancer: The Atherosclerosis Risk in Communities Study (ARIC)Anna E Prizment, Amy M Linabery, Pamela L Lutsey, et al.
Cancer Causes & Control : CCC|February 6, 2010
Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studiesElizabeth A Platz, Siobhan Sutcliffe, Angelo M De Marzo, et al.
International Journal of Cancer|February 5, 2015
Asthma and risk of lethal prostate cancer in the Health Professionals Follow-Up StudyElizabeth A Platz, Charles G Drake, Kathryn M Wilson, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy responseCasey R Ager, Mingxuan Zhang, Matthew Chaimowitz, et al.
Journal of the National Cancer Institute|March 8, 2020
Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-TRavi A Madan, Emmanuel S Antonarakis, Charles G Drake, et al.
Cancer Investigation|June 24, 2010
Immune signatures predict prognosis in localized cancerDavid S Hsu, Mickey K Kim, Bala S Balakumaran, et al.
Cancer Immunology Research|June 7, 2015
A Paracrine Role for IL6 in Prostate Cancer Patients: Lack of Production by Primary or Metastatic Tumor CellsShu-Han Yu, Qizhi Zheng, David Esopi, et al.
Pageof 27